Volume 26, Number 11—November 2020
Research Letter
Four Patients with COVID-19 and Tuberculosis, Singapore, April–May 2020
Table
Pt no. | Age, y/sex, nationality | Initial signs/symptoms | Radiologic findings | Pleural fluid analysis | Sputum analysis | Microbiological findings | IGRA for TB | Outcome |
---|---|---|---|---|---|---|---|---|
1† |
32/M, India |
Fever, productive cough |
CXR: right upper zone and left lower zone cavitary lesions;
chest CT: irregular opacifications with central cavitation |
NA |
AFB smear negative; molecular TB analysis negative |
Sputum AFB culture negative |
+ |
Symptoms resolved; repeat CXR after starting ATT demonstrated resolution of cavitary lesions at 2 mo of treatment |
2 |
33/M, India |
Fever, nonproductive cough; 3-kg weight loss over 1 mo |
CXR: right-sided pleural effusion;
chest CT: loculated right-sided effusion with adjacent collapse/consolidation |
Lymphocytic exudative effusion; ADA 130 U/L;
SARS-CoV-2 PCR negative |
AFB smear negative;
molecular TB analysis negative |
Sputum and pleural fluid AFB cultures pending |
+ |
Symptoms resolved with interval improvement of CXR |
3† |
22/M, India |
Fever, nonproductive cough; exertional dyspnea, pleuritic chest pain |
CXR: right-sided pleural effusion with adjacent compressive atelectasis |
Lymphocytic exudative effusion; ADA 112 U/L;
SARS-CoV-2 PCR negative |
AFB smear negative;
molecular TB analysis negative |
Sputum and pleural fluid AFB cultures pending |
+ |
Symptoms resolved with interval improvement of CXR |
4 | 40/M, Bangladesh | Fever, productive cough; reduced effort tolerance | CXR: large left-sided pleural effusion; Chest CT: left-sided pleural effusion, bilateral patchy consolidative changes with ground-glass opacities and interlobular septal thickening | Lymphocytic exudative effusion; ADA 69 U/L; SARS-CoV-2 PCR negative | AFB smear negative; molecular TB analysis negative | Sputum AFB culture negative; pleural fluid AFB culture positive for Mycobacterium tuberculosis complex | + | Symptoms resolved with interval improvement of CXR |
*ADA, adenosine deaminase; AFB, acid-fast bacilli; ATT, anti-TB therapy; CT, computed tomography image; CXR, plain chest radiograph; IGRA, interferon gamma release assay; NA, not applicable; Pt, patient; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; TB, tuberculosis; +, positive. †These patients reside in the same dormitory.
Page created: July 15, 2020
Page updated: October 19, 2020
Page reviewed: October 19, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.